Tavegyl, Tabletten

7680336670356 CH-33667 Tabletten

Associated product:

TAVEGYL cpr 1 mg 20 pce
Tavegyl, Tabletten
Tavegyl, Tabletten
Tavegyl, Tabletten
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Tablette(n)
Galenic form
Tabletten
Galenic group
Tabletten

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
31/08/2021
Patient information leaflet
Français
31/08/2021
Patient information leaflet
Italien
31/08/2021
Summary of Product Characteristics
Allemand
31/08/2021
Summary of Product Characteristics
Français
31/08/2021
Summary of Product Characteristics
Italien
31/08/2021

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
107.66 MG Substance HBESI

Authorization holder

Spirig HealthCare AG

4622 Egerkingen

Authorization information

Swissmedic authorization number
33667
Drug name
Tavegyl, Tabletten
Galenic form
TAB
ATC Code
R06AA04
Authorization status
Z
Dispensing category
D
First authorization
17/10/1967
Authorization expiration date
31/12/9999
IT Number
07.13.1.
Domain
Human medicine
Field of application
Antihistaminikum

Package details

Description (FR)
TAVEGYL cpr 1 mg 20 pce
Description (DE)
TAVEGYL Tabl 1 mg 20 Stk
Market launch
17/10/1967
Narcotic (BTM)
No